A 50 year has tongue cancer and on active chemotherapy has develop acu

A 50 year has tongue cancer and on active chemotherapy has develop acute swelling under chin right side , swelling is hard in nature and fix , no any other symptoms

Reading File

Finding Sources

Searching PubMed

"tongue cancer" AND "neck metastasis" AND chemotherapy

Finding Sources

Searching PubMed

"oral tongue" AND "cervical lymph node" AND metastasis

Reading File

Finding Sources

Reading File

Loading Image

Now I have all the information needed for a thorough clinical answer.

Clinical Assessment: Hard, Fixed Submental Swelling in a Tongue Cancer Patient on Chemotherapy

Most Likely Diagnosis: Nodal Metastasis (Level IA - Submental lymph node)

The clinical picture here is highly suspicious for regional lymph node metastasis, specifically to the submental (Level IA) lymph node, representing either:

New nodal metastasis during chemotherapy (disease progression/chemotherapy failure), or
Progression of a previously existing occult nodal deposit that is now clinically apparent

The hallmarks pointing squarely toward malignant nodal disease are:

Hard consistency - metastatic nodes are typically firm to hard (as opposed to soft, fluctuant nodes seen in abscess or reactive lymphadenitis)
Fixed nature - fixation indicates extracapsular spread (ECS) with invasion into surrounding soft tissue, a particularly ominous sign
No other symptoms - no fever, no local warmth/redness that would suggest infection

Anatomy - Why Submental (Level I) for Tongue Cancer?

Level I (submental + submandibular) is the first-echelon drainage for the anterior oral tongue, floor of mouth, and buccal mucosa
Oral cavity cancers classically metastasize to Levels I, II, and III
Anterior tongue cancer in particular drains to Level IA (submental) and can even involve the contralateral neck

Per Cummings Otolaryngology: "The nodes in the submandibular triangle are frequently involved in patients with carcinoma of the floor of the mouth, anterior oral tongue, and buccal mucosa."

Per Sabiston Textbook of Surgery: "Oral cavity cancers commonly metastasize to levels I-III... Lymphadenopathy seen in distant levels, such as level V, may suggest a more advanced degree of spread and thus a poorer prognosis."

Differential Diagnosis

Diagnosis	For	Against
Nodal metastasis (most likely)	Hard, fixed, known tongue cancer, Level I location, on chemo (may suggest resistance)	-
Reactive lymphadenopathy	Known malignancy present	Soft/mobile nodes; hard & fixed favors malignancy
Abscess/infected node	Immunocompromised on chemo	No fever, not fluctuant, hard not soft, no erythema
Ludwig's angina	Submandibular/submental area	Hard fixed, no sepsis signs, floor of mouth not indurated
Salivary gland pathology	Submental region	Unilateral, fixed, no glandular symptoms
Second primary	Patient has known cancer	Less likely acutely

Clinical Significance of "Fixed" Node

A fixed lymph node in the context of malignancy implies extracapsular extension (ECE), which:

Upstages the nodal disease (changes N1 to N3b in AJCC 8th edition for H&N)
Makes surgical resection more complex
Mandates adjuvant radiotherapy ± chemotherapy post-surgery
Carries a significantly worse prognosis

Immediate Workup Required

Imaging (CECT neck, chest, abdomen-pelvis)
- Assess the node: size, internal necrosis, extracapsular spread, relation to adjacent vessels (carotid, IJV)
- Rule out distant metastases
- MRI preferred for soft-tissue detail when feasible
FNAC or Core Biopsy of the node
- Confirm metastatic SCC vs. other pathology
- Assess for HPV/p16 status if not already done
PET-CT (if available)
- Full-body staging to rule out systemic disease
- Assess true extent of nodal involvement
Review of primary tumor - is the tongue primary also progressing?
Reassess chemotherapy regimen - new nodal disease while on active chemo signals possible chemotherapy failure/resistance

Management Implications

Since this patient is already on active chemotherapy and has developed a new fixed nodal mass, this is a red flag for treatment failure:

If confirmed as nodal progression: the current chemotherapy regimen is likely ineffective
Per Goldman-Cecil Medicine: In recurrent/metastatic HNSCC, pembrolizumab (anti-PD-1), either as monotherapy or combined with platinum + 5-FU, is the standard salvage systemic therapy
For platinum-refractory disease: nivolumab or pembrolizumab improves survival
Multidisciplinary team (surgical oncology, radiation oncology, medical oncology) review is essential
If disease is resectable: salvage surgery + post-op radiotherapy may be considered
Palliative/supportive care discussion if disease is unresectable

Key Points Summary

A hard, fixed submental swelling in a known tongue cancer patient = metastatic lymph node (Level IA) until proven otherwise
The fixed nature suggests extracapsular spread - this is not a benign reactive node
The fact that it appeared during active chemotherapy raises serious concern for chemotherapy resistance/progression
Urgent imaging + biopsy is needed
Refer promptly to the treating oncology/ENT team for multidisciplinary reassessment and likely regimen change

Sources: Cummings Otolaryngology Head and Neck Surgery, p.2298; Sabiston Textbook of Surgery, p.938; Goldman-Cecil Medicine, p.2017

This is a shared conversation. Sign in to Orris to start your own chat.